John Kenneth Amory

Insider Reports History

Location
Northbrook, IL
Signature
/s/ Steven A. Bourne, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Kenneth Amory:

Company Role Class Num Shares Value Price $ Report Date Ownership
Clarus Therapeutics Holdings, Inc. Director Common Stock 5,766 07 Jun 2022 Direct
Clarus Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 4,805 07 Jun 2022 Direct

Insider Reports Filed by John Kenneth Amory

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322021756-amory-john-kenneth-2022-06-07 Clarus Therapeutics Holdings, Inc. 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 20:02
/report/000089924321048207-amory-john-kenneth-2021-12-12 Clarus Therapeutics Holdings, Inc. 12 Dec 2021 2 $0 4 Director 14 Dec 2021, 18:00
/report/000121390021047824-amory-john-kenneth-2021-09-09 Clarus Therapeutics Holdings, Inc. 09 Sep 2021 0 $0 3 Director 13 Sep 2021, 20:39